UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Phase I metabolism of the highly potent synthetic cannabinoid MDMB‐CHMICA and detection in human urine samples

Drug testing and analysis, 2017-05, Vol.9 (5), p.744-753

2017

Volltextzugriff (PDF)

Metabolites of synthetic cannabinoids in hair—proof of consumption or false friends for interpretation?

Analytical and bioanalytical chemistry, 2016-05, Vol.408 (13), p.3445-3452

2016

Volltextzugriff (PDF)

Detection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokinetics

Journal of mass spectrometry., 2013-11, Vol.48 (11), p.1150-1159

2013

Volltextzugriff (PDF)

Detection of the recently emerged synthetic cannabinoid 5F–MDMB‐PICA in ‘legal high’ products and human urine samples

Drug testing and analysis, 2018-01, Vol.10 (1), p.196-205

2018

Volltextzugriff (PDF)

Investigation of the in vitro toxicological properties of the synthetic cannabimimetic drug CP-47,497-C8

Toxicology and applied pharmacology, 2014-06, Vol.277 (2), p.164-171

2014

Volltextzugriff (PDF)

5F-Cumyl-PINACA in ‘e-liquids’ for electronic cigarettes: comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACA

Forensic toxicology, 2019-01, Vol.37 (1), p.186-196

2019

Volltextzugriff (PDF)

Separation and structural characterization of the synthetic cannabinoids JWH-412 and 1-[(5-fluoropentyl)-1H-indol-3yl]-(4-methylnaphthalen-1-yl)methanone using GC–MS, NMR analysis and a flash chromatography system

Forensic science international, 2012-07, Vol.220 (1), p.e17-e22

2012

Volltextzugriff (PDF)

Hair analysis for THCA-A, THC and CBN after passive in vivo exposure to marijuana smoke

Drug testing and analysis, 2014-01, Vol.6 (1-2), p.119-125

2014

Volltextzugriff (PDF)

Inhomogeneities in herbal mixtures: a serious risk for consumers

Forensic toxicology, 2015-01, Vol.33 (1), p.54-60

2015

Volltextzugriff (PDF)

Characterization of the four designer benzodiazepines clonazolam, deschloroetizolam, flubromazolam, and meclonazepam, and identification of their in vitro metabolites

Forensic toxicology, 2015-07, Vol.33 (2), p.388-395

2015

Volltextzugriff (PDF)

Novel Receptor-Binding-Based Assay for the Detection of Opioids in Human Urine Samples

Analytical chemistry (Washington), 2023-02, Vol.95 (5), p.2723-2731

2023

Volltextzugriff (PDF)

Phase I metabolism of the carbazole‐derived synthetic cannabinoids EG‐018, EG‐2201, and MDMB‐CHMCZCA and detection in human urine samples

Drug testing and analysis, 2018-09, Vol.10 (9), p.1417-1429

2018

Volltextzugriff (PDF)

Characterization of the designer benzodiazepine pyrazolam and its detectability in human serum and urine

Forensic toxicology, 2013-07, Vol.31 (2), p.263-271

2013

Volltextzugriff (PDF)

Development of a non-radioactive mass spectrometry-based binding assay at the μ-opioid receptor and its application for the determination of the binding affinities of 17 opiates/opioids as well as of the designer opioid isotonitazene and five further 2-benzylbenzimidazoles

Analytica chimica acta, 2022-08, Vol.1219, p.339978-339978, Article 339978

2022

Volltextzugriff (PDF)

Hair analysis for JWH-018, JWH-122, and JWH-210 after passive in vivo exposure to synthetic cannabinoid smoke

Forensic toxicology, 2015-01, Vol.33 (1), p.69-76

2015

Volltextzugriff (PDF)

Hair analysis for Δ9-tetrahydrocannabinolic acid A (THCA-A) and Δ9-tetrahydrocannabinol (THC) after handling cannabis plant material

Drug testing and analysis, 2016-01, Vol.8 (1), p.128-132

2016

Volltextzugriff (PDF)

Stability of 11 prevalent synthetic cannabinoids in authentic neat oral fluid samples: glass versus polypropylene containers at different temperatures

Drug testing and analysis, 2013-07, Vol.5 (7), p.602-606

2013

Volltextzugriff (PDF)

Cross reactivity of the CEDIA and HEIA benzodiazepine kits for 29 designer benzodiazepines and tofisopam

Drug testing and analysis, 2021-09, Vol.13 (9), p.1686-1688

2021

Volltextzugriff (PDF)

Hair analysis of synthetic cannabinoids: does the handling of herbal mixtures affect the analyst’s hair concentration?

Forensic toxicology, 2015-01, Vol.33 (1), p.37-44

2015

Volltextzugriff (PDF)

Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolism

Journal of mass spectrometry., 2013-07, Vol.48 (7), p.885-894

2013

Volltextzugriff (PDF)

Designer Benzodiazepines: Another Class of New Psychoactive Substances

New Psychoactive Substances, 2018, Vol.252, p.383-410

2018

Volltextzugriff (PDF)

Finding cannabinoids in hair does not prove cannabis consumption

Scientific reports, 2015-10, Vol.5 (1), p.14906, Article 14906

2015

Volltextzugriff (PDF)

Development and validation of an LC-MS/MS method for quantification of Delta 9-tetrahydrocannabinolic acid A (THCA-A), THC, CBN and CBD in hair

Journal of mass spectrometry., 2013-02, Vol.48 (2), p.227-233

2013

Volltextzugriff (PDF)

Development and validation of an LC-MS/MS method for quantification of Δ9-tetrahydrocannabinolic acid A (THCA-A), THC, CBN and CBD in hair

Journal of mass spectrometry., 2013-02, Vol.48 (2), p.227-233

2013

Volltextzugriff (PDF)

Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics

Drug testing and analysis, 2014-07, Vol.6 (7-8), p.757-763

2014

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(47)

Publikationsform

Sprache

Englisch
(47)
Japanisch
(11)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase I metabolism of the highly potent synthetic cannabinoid MDMB‐CHMICA and detection in human urine samples

Metabolites of synthetic cannabinoids in hair—proof of consumption or false friends for interpretation?

Detection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokinetics

Detection of the recently emerged synthetic cannabinoid 5F–MDMB‐PICA in ‘legal high’ products and human urine samples

Investigation of the in vitro toxicological properties of the synthetic cannabimimetic drug CP-47,497-C8

5F-Cumyl-PINACA in ‘e-liquids’ for electronic cigarettes: comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACA

Separation and structural characterization of the synthetic cannabinoids JWH-412 and 1-[(5-fluoropentyl)-1H-indol-3yl]-(4-methylnaphthalen-1-yl)methanone using GC–MS, NMR analysis and a flash chromatography system

Hair analysis for THCA-A, THC and CBN after passive in vivo exposure to marijuana smoke

Inhomogeneities in herbal mixtures: a serious risk for consumers

Characterization of the four designer benzodiazepines clonazolam, deschloroetizolam, flubromazolam, and meclonazepam, and identification of their in vitro metabolites

Novel Receptor-Binding-Based Assay for the Detection of Opioids in Human Urine Samples

Phase I metabolism of the carbazole‐derived synthetic cannabinoids EG‐018, EG‐2201, and MDMB‐CHMCZCA and detection in human urine samples

Characterization of the designer benzodiazepine pyrazolam and its detectability in human serum and urine

Development of a non-radioactive mass spectrometry-based binding assay at the μ-opioid receptor and its application for the determination of the binding affinities of 17 opiates/opioids as well as of the designer opioid isotonitazene and five further 2-benzylbenzimidazoles

Hair analysis for JWH-018, JWH-122, and JWH-210 after passive in vivo exposure to synthetic cannabinoid smoke

Hair analysis for Δ9-tetrahydrocannabinolic acid A (THCA-A) and Δ9-tetrahydrocannabinol (THC) after handling cannabis plant material

Stability of 11 prevalent synthetic cannabinoids in authentic neat oral fluid samples: glass versus polypropylene containers at different temperatures

Cross reactivity of the CEDIA and HEIA benzodiazepine kits for 29 designer benzodiazepines and tofisopam

Hair analysis of synthetic cannabinoids: does the handling of herbal mixtures affect the analyst’s hair concentration?

Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolism

Designer Benzodiazepines: Another Class of New Psychoactive Substances

Finding cannabinoids in hair does not prove cannabis consumption

Development and validation of an LC-MS/MS method for quantification of Delta 9-tetrahydrocannabinolic acid A (THCA-A), THC, CBN and CBD in hair

Development and validation of an LC-MS/MS method for quantification of Δ9-tetrahydrocannabinolic acid A (THCA-A), THC, CBN and CBD in hair

Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics

Suchergebnisse filtern